Congenital lung abnormality lung abnormality
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Lesion detected during routine prenatal ultrasound screening - Delivery at term: gestational age >=37 weeks - Birthweight > -2SD or >P10 - Asymptomatic at birth defined as no prolonged respiratory distress or oxygen support (
Exclusion criteria
Exclusion criteria: - Bilateral lesion - Development of symptoms before randomization, considered by treating physician as caused by CPAM with reasonable certainty - Complicated pregnancy defined as (pre-)eclampsia, pregnancy diabetes in mother, foetal hydrops or severe polyhydramnios on prenatal ultrasound - Syndrome associated anomalies on genetic analysis confirmed by genetic expert - Major associated malformations. Anomalies include cardiac malformations requiring surgical correction or follow-up by a paediatric cardiologist, congenital malformations requiring major surgical intervention, and anomalies that affect normal lung growth and development. - Suspicion of malignancy on chest CT scan evaluation at the age of 3-9 months - Participation in another randomised controlled trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the difference in maximal endurance using the BRUCE treadmill test at five years of age between the surgical and conservative group, measured in minutes and SDS. | — |
Secondary
| Measure | Time frame |
|---|---|
| o Pulmonary morbidity during follow-up (occurrence of infections, cough, dyspnoea, respiratory insufficiency and other pulmonary symptoms). o Frequency of surgical intervention due to pulmonary morbidity during follow-up period o CPAM characteristics on prenatal ultrasound images, reported according to structured report, see Appendix D (35) o CPAM characteristics on CT-scan at 3-9 months of age, reported according to structured report form Appendix C (34) o CPAM development / post-surgical appearance on repeated CT imaging, reported according to structured report form (34) o Parental anxiety, pre-operative and at all follow-up visits by means of the Visual Analogue Scale for Anxiety (VAS-A) (38, 39) o Quality of life analysis by means of the Infant Toddler Quality of Life Questionnaire (ITQOL) (40) o Pathological characteristics of resected material (macroscopic, microscopic, immunohistochemistry, molecular diagnostics) as assessed by local pathologist of participating centre according to Appendix B (23) o Abnormal anthropometric measurements during follow-up, measured with help of local SD-score computation o Analysis of the cost-effectiveness of both management strategies and comparison between them, see chapter 10-c | — |
Countries
Netherlands